Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran PK/PD in Children with VTE
NCT01083732Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2010
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Started Mar 2010; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01083732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01083732.